medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2021, Number 02

<< Back Next >>

Ginecol Obstet Mex 2021; 89 (02)

Evaluation of genitourinary syndrome of menopause with the Vulvovaginal Symptoms Questionnaire in Afro-descendants of the Colombian Caribbean

Monterrosa-Castro Á, Redondo-Mendoza V, Monterrosa-Blanco A

Language: Spanish
References: 37
Page: 115-128
PDF size: 232.48 Kb.


ABSTRACT

Objective: To estimate the prevalence of the genitourinary syndrome of menopause, to establish its impact on sexuality, on emotional life and to establish the association with menstrual status and postmenopausal stages.
Materials and Methods: Transversal study carried out in 2019 in Afrodescendant women of the Colombian Caribbean, in the climacteric stage, captured in their residences and surveyed with the Vulvovaginal Symptoms Questionnaire. Unadjusted multivariate logistic regression was performed: genitourinary syndrome of menopause and its repercussions (dependent variables), menstrual status, and postmenopausal stages (independent variables). Anonymous voluntary evaluation with informed consent.
Results: 369 patients of African descent from the Colombian Caribbean were surveyed, with 49.1 ± 5.8 years. The 66.3% were early postmenopausal and 33.7% late. 86.2% were sexually active. The most frequent symptoms were: irritation, itching and vulvovaginal dryness. 23.3% (86 of 369) had genitourinary syndrome of menopause. 14% of the women with this syndrome who were sexually active reported an impairment of desire. In 20.6% (14 of 68) was identified affectation in sexuality, in 22.1% (19 of 86) impact on quality of life and 25.6% (22 of 86) in the emotional area. No association was found between menstrual states, postmenopausal stages and genitourinary syndrome of menopause (p › 0.05).
Conclusions: A significant percentage (23.3%) of the women surveyed had genitourinary menopause syndrome. Twenty percent of those affected expressed repercussions on sexuality, daily life, and emotions. In this group of Colombian Afro-descendants, no association between the stages of menopause and the syndrome assessed was observed in the climacteric.


REFERENCES

  1. Portman DJ, Gass ML. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women’s Sexual Health and the North American Menopause Society. J Sex Med. 2014; 11 (12): 2865-72. https://doi.org/10.1111/ jsm.12686.

  2. Vieira-Baptista P, Marchitelli C, Haefner HK, Donders G, Pérez-López F. Deconstructing the genitourinary syndrome of menopause. Int Urogynecol J. 2017; 28 (5): 675-79. https://doi.org/10.1007/s00192-017-3295-6.

  3. The North American Menopause Society (NAMS). The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society. Menopause. 2020; 27 (9): 976-992. doi.10.1097/ GME.0000000000001609.

  4. Huang AJ, Gregorich SE, Kuppermann M, et al. Day-to- Day Impact of Vaginal Aging questionnaire: a multidimensional measure of the impact of vaginal symptoms on functioning and well-being in postmenopausal women. Menopause. 2015; 22 (2): 144-154. doi.10.1097/ GME.0000000000000281.

  5. Erekson EA, Yip SO, Wedderburn TS, et al. The Vulvovaginal Symptoms Questionnaire: a questionnaire for measuring vulvovaginal symptoms in postmenopausal women. Menopause. 2013; 20 (9): 973-79. doi.10.1097/ GME.0b013e318282600b.

  6. Nappi RE, Kokot-Kierepa M. Vaginal Health: Insights, Views & Attitudes (VIVA) - results from an international survey. Climacteric. 2012; 15 (1): 36-44. doi.10.3109/13697137 .2011.647840.

  7. Nappi RE, Particco M, Biglia N, et al. Attitudes and perceptions towards vulvar and vaginal atrophy in Italian post-menopausal women: Evidence from the European REVIVE survey. Maturitas. 2016; 91: 74-80. doi.10.1016/j. maturitas.2016.06.009.

  8. Kingsberg SA, Krychman M, Graham S, Bernick B, Mirkin S. The Women’s EMPOWER Survey: Identifying Women’s Perceptions on Vulvar and Vaginal Atrophy and Its Treatment. J Sex Med. 2017; 14 (3): 413-24. doi.10.1016/j. jsxm.2017.01.010.

  9. Nappi RE, Kingsberg S, Maamari R, Simon J. The CLOSER (CLarifying Vaginal Atrophy’s Impact On SEx and Relationships) survey: implications of vaginal discomfort in postmenopausal women and in male partners. J Sex Med. 2013; 10 (9): 2232-41. doi.10.1111/jsm.12235.

  10. Erekson EA, Li FY, Martin DK, Fried TR. Vulvovaginal symptoms prevalence in postmenopausal women and relationship to other menopausal symptoms and pelvic floor disorders. Menopause. 2016; 23 (4): 368-75. doi.10.1097/ GME.0000000000000549.

  11. Fernández-Alonso AM, Alcaide-Torres J, Fernández-Alonso IM, Chedraui P, Pérez-López FR. Application of the 21-item Vulvovaginal Symptoms Questionnaire in postmenopausal Spanish women. Menopause. 2017; 24 (11): 1295-301. doi.10.1097/GME.0000000000000948.

  12. Nappi RE, de Melo NR, Martino M, et al. Vaginal Health: Insights, Views & Attitudes (VIVA-LATAM): results from a survey in Latin America. Climacteric. 2018; 21 (4): 397-403. doi.10.1080/13697137.2018.1461826.

  13. Nappi RE, Palacios S. Impact of vulvovaginal atrophy on sexual health and quality of life at postmenopause. Climacteric. 2014; 17 (1): 3-9. doi.10.3109/13697137.2 013.871696.

  14. Nappi RE, Palacios S, Bruyniks N, Particco M, Panay N; EVES Study investigators. The burden of vulvovaginal atrophy on women’s daily living: implications on quality of life from a face-to-face real-life survey. Menopause. 2019; 26 (5): 485-91. doi.10.1097/GME.0000000000001260.

  15. Hunter MM, Nakagawa S, Van Den Eeden SK, Kuppermann M, Huang AJ. Predictors of impact of vaginal symptoms in postmenopausal women. Menopause. 2016; 23 (1): 40-46. doi.10.1097/GME.0000000000000482.

  16. Huang AJ, Luft J, Grady D, Kuppermann M. The day-to-day impact of urogenital aging: perspectives from racially/ ethnically diverse women. J Gen Intern Med. 2010; 25 (1): 45-51. doi.10.1007/s11606-009-1135-1.

  17. Richard-Davis G, Wellons M. Racial and ethnic differences in the physiology and clinical symptoms of menopause. Semin Reprod Med. 2013; 31 (5): 380-86. doi.10.1055/s-0033-1348897.

  18. Monterrosa A, Blumel JE, Chedraui P. Increased menopausal symptoms among Afro-Colombian women as assessed with the Menopause Rating Scale. Maturitas. 2008; 59 (2): 182-90. doi.10.1016/j.maturitas.2007.12.002.

  19. República de Colombia. Ministerio de Salud [MSPS]. Resolución 8430-1993. Normas científicas, técnicas y administrativas para la investigación en salud Biomédica. [En línea] Dirección URL: https://www.minsalud.gov.co/ sites/rid/Lists/BibliotecaDigital/RIDE/DE/DIJ/RESOLUCION- 8430-DE-1993.PDF.

  20. Gabes M, Knüttel H, Stute P, Apfelbacher CJ. Measurement properties of patient-reported outcome measures (PROMs) for women with genitourinary syndrome of menopause: a systematic review. Menopause. 2019; 26 (11): 1342-53. doi.10.1097/GME.0000000000001390.

  21. Harlow SD, Gass M, Hall JE, et al. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. Fertil Steril. 2012; 97 (4): 843-51. doi.10.1016/j. fertnstert.2012.01.128.

  22. República De Colombia. Departamento Administrativo Nacional de Estadística [DANE]. Censo General 2005. https:// www.dane.gov.co/index.php/estadisticas-por-tema/ demografia-y-poblacion/censo-general-2005-1.

  23. DiBonaventura M, Luo X, Moffatt M, Bushmakin AG, Kumar M, Bobula J. The Association Between Vulvovaginal Atrophy Symptoms and Quality of Life Among Postmenopausal Women in the United States and Western Europe. J Womens Health (Larchmt). 2015; 24 (9): 713-22. doi.10.1089/ jwh.2014.5177.

  24. Faubion SS, Sood R, Kapoor E. Genitourinary Syndrome of Menopause: Management Strategies for the Clinician. Mayo Clin Proc. 2017;92(12):1842-1849. doi.10.1016/j. mayocp.2017.08.019.

  25. Geng L, Zheng Y, Zhou Y, Li C, Tao M. The prevalence and determinants of genitourinary syndrome of menopause in Chinese mid-life women: a single-center study. Climacteric. 2018; 21 (5): 478-82. doi.10.1080/13697137.2018.1458832.

  26. Srisukho S, Pantasri T, Piyamongkol W, Phongnarisorn C, Morakote N. The experience of genitourinary syndrome of menopause (GSM) among Thai postmenopausal women: the non-reporting issue. Int Urogynecol J. 2019; 30 (11): 1843-47. doi.10.1007/s00192-019-03991-0.

  27. Moral E, Delgado JL, Carmona F, et al. Genitourinary syndrome of menopause. Prevalence and quality of life in Spanish postmenopausal women. The GENISSE study. Climacteric. 2018; 21 (2): 167-73. doi.10.1080/1369713 .2017.1421921.

  28. Palma F, Volpe A, Villa P, Cagnacci A; Writing group of AGATA study. Vaginal atrophy of women in postmenopause. Results from a multicentric observational study: The AGATA study. Maturitas. 2016; 83: 40-44. doi.10.1016/j. maturitas.2015.09.001.

  29. Espitia De La Hoz FJ. Prevalencia del síndrome genitourinario de la menopausia en mujeres e impacto en la sexualidad, en Quindío (Colombia), 2013-2016. Rev Colomb Obstet Ginecol. 2018; 69 (4): 249-59. https://doi. org/10.18597/rcog.3111.

  30. Handa VL, Lockhart ME, Fielding JR, et al. Racial differences in pelvic anatomy by magnetic resonance imaging. Obstet Gynecol. 2008; 111 (4): 914-20. doi.10.1097/ AOG.0b013e318169ce03.

  31. Scavello I, Maseroli E, Di Stasi V, Vignozzi L. Sexual Health in Menopause. Medicina (Kaunas). 2019; 55 (9): 559. doi.10.3390/medicina55090559.

  32. Pinkerton JV, Bushmakin AG, Komm BS, Abraham L. Relationship between changes in vulvar-vaginal atrophy and changes in sexual functioning. Maturitas. 2017; 100: 57-63. doi.10.1016/j.maturitas.2017.03.315.

  33. Avis NE, Colvin A, Karlamangla AS, et al. Change in sexual functioning over the menopausal transition: results from the Study of Women’s Health Across the Nation. Menopause. 2017; 24 (4): 379-90. doi.10.1097/GME.0000000000000770.

  34. Avis NE, Brockwell S, Randolph JF Jr, et al. Longitudinal changes in sexual functioning as women transition through menopause: results from the Study of Women’s Health Across the Nation. Menopause. 2009; 16 (3): 442-52. doi.10.1097/gme.0b013e3181948dd0.

  35. Makuwa GN, Rikhotso SR, Mulaudzi FM. The perceptions of African women regarding natural menopause in Mamelodi, Tshwane district. Curationis. 2015; 38 (2): 1531. http:// dx.doi.org/10.4102/curationis.v38i2.1531.

  36. Rice VM. Strategies and issues for managing menopauserelated symptoms in diverse populations: ethnic and racial diversity. Am J Med. 2005; 118 Suppl 12B: 142-47. https:// doi.org/10.1016/j.amjmed.2005.09.048.

  37. Krychman M, Graham S, Bernick B, Mirkin S, Kingsberg SA. The Women’s EMPOWER Survey: Women’s Knowledge and Awareness of Treatment Options for Vulvar and Vaginal Atrophy Remains Inadequate. J Sex Med. 2017; 14 (3): 425- 33. https://doi.org/10.1016/j.jsxm.2017.01.011.




2020     |     www.medigraphic.com